Patents Prosecuted
Application number | Title of the patent | IPC | Filing Date | Decision Date |
---|---|---|---|---|
17194699 | COMPOSITIONS AND METHODS FOR QUANTIFYING INTEGRATION OF RECOMBINANT VECTOR NUCLEIC ACID | C12Q | Mar 7, 2021 | |
17190566 | GAMMA DELTA T CELLS AND USES THEREOF | C12N, C07K, A61K | Mar 2, 2021 | |
17186704 | MATERIALS AND METHODS FOR MODULATING AN IMMUNE RESPONSE | C07K | Feb 25, 2021 | |
17174505 | Neoantigens expressed in ovarian cancer and their uses | C12N, A61K, C07K | Feb 11, 2021 | Apr 1, 2024 |
17174590 | NEOANTIGENS EXPRESSED IN MULTIPLE MYELOMA AND THEIR USES | A61P, C07K, A61K | Feb 11, 2021 | |
17174386 | Treatment of Patients Having c-Met Exon 14 Skipping Mutations | C07K, A61P, A61K | Feb 11, 2021 | |
17174524 | EGFR and C-Met Fibronectin Type III Domain Binding Molecules | C07K | Feb 11, 2021 | |
17160087 | DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS INTO PANCREATIC ENDOCRINE CELLS USING HB9 REGULATORS | C12N | Jan 26, 2021 | |
17153229 | Serum albumin-binding fibronectin type III domains | C07K, A61K, G01N | Jan 19, 2021 | Dec 4, 2023 |
17149544 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | A61K, C07K | Jan 13, 2021 | |
17149509 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | A61K, C07K | Jan 13, 2021 | Dec 18, 2023 |
17125263 | Antibodies that specifically bind PD-1 and methods of use | C07K, C12N, A61P, A61K | Dec 16, 2020 | Sep 4, 2023 |
17125162 | MATERIALS AND METHODS FOR IN VIVO BIOLOGICAL TARGETING | B01D, C07K | Dec 16, 2020 | Sep 9, 2023 |
17783807 | SMART PILL BOTTLE CAPS | A61J | Dec 9, 2020 | |
17115036 | Method for determining severity of skin disease based on percentage of body surface area covered by lesions | G06T | Dec 7, 2020 | Dec 26, 2022 |
17785778 | LIQUID DRUG PUMPS INCLUDING USER FEEDBACK INDICATING PUMP ORIENTATION | A61M | Dec 3, 2020 | |
17786313 | LIQUID DRUG PUMPS WITH A FLEXIBLE DRUG RESERVOIR | A61M | Dec 1, 2020 | |
17104081 | PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS | A61P, C07D | Nov 24, 2020 | |
17103260 | TREATMENT OF HIDRADENITIS SUPPURATIVA | C07K, A61P | Nov 23, 2020 | Jan 4, 2024 |
16950244 | USE OF SMALL MOLECULES TO ENHANCE MAFA EXPRESSION IN PANCREATIC ENDOCRINE CELLS | C12N | Nov 16, 2020 |